At inHEART, we’re transforming cardiology through two strategic collaborations with Dassault Systèmes, Philips Cardiologs, Incepto, and IHU Lyric.
Our AI-based digital twin technology tackles critical challenges like Sudden Cardiac Death and Cardioembolic Stroke, shifting healthcare from reactive to proactive. Through these powerful partnerships, we’re validating innovative solutions for prevention and screening, setting new standards in cardiac health.
MEDITWIN —a consortium with Dassault Systèmes—leverages inHEART’s AI-based digital twin technology to identify patients for early preventive treatment at risk of Sudden Cardiac Death through risk stratification using cardiac CT and ECG for patient selection. By analyzing clinical data, we enable earlier interventions and better outcomes.
inHEART’s AI is designed to simulate electrical activity to precisely pinpoint the origins of ventricular fibrillation, empowering faster and more accurate diagnosis.
Partners:
TALENT—a collaboration with 9 academic, hospital, and industrial partners—uses AI-based digital twins to screen for Cardioembolic Stroke risk via chest CT and ECG, outperforming the anticoagulant therapy based on the CHA₂DS₂-VASc score and LAA occlusion.
inHEART’s AI will provide a multivariable prediction model based on CT data, helping physicians better assess and manage stroke risk.
Partners:
This work received support from the French government managed by the French National Research Agency (ANR) under the France 2030 program, reference ANR-23-RHUS-0015.
